Specialist - QA Ops - Manufacturing Management |
Tuas South Avenue |
Singapour |
Operations |
Innovative Medicines |
Qualité |
fév 25, 2025 |
Medical Lead |
Mapletree Business City (MBC) |
Singapour |
International |
Innovative Medicines |
Recherche & Développement |
fév 25, 2025 |
Specialist - QA Ops - Manufacturing Mgmt |
Tuas South Avenue |
Singapour |
Operations |
Innovative Medicines |
Qualité |
fév 24, 2025 |
AS&T Expert (Micro) |
Tuas South Avenue |
Singapour |
Operations |
Innovative Medicines |
Qualité |
fév 24, 2025 |
Business Excellence & Execution Lead, APMA |
Mapletree Business City (MBC) |
Singapour |
International |
Innovative Medicines |
Commercialisation |
fév 18, 2025 |
Equipment specialist I |
Tuas South Avenue |
Singapour |
Operations |
Innovative Medicines |
Opérations techniques |
fév 14, 2025 |
Value and Access Specialist |
Mapletree Business City (MBC) |
Singapour |
International |
Innovative Medicines |
Accès au marché |
fév 11, 2025 |
Executive Director, Public Affairs Asia Aspiring |
Mapletree Business City (MBC) |
Singapour |
People & Organization |
Corporate |
Communications & Public Affairs |
fév 10, 2025 |
Director, Portfolio Advocacy APMA |
Mapletree Business City (MBC) |
Singapour |
People & Organization |
Innovative Medicines |
Communications & Public Affairs |
fév 10, 2025 |
Cell Therapy Operations Manager |
Mapletree Business City (MBC) |
Singapour |
International |
Innovative Medicines |
BDL et planification stratégique |
fév 06, 2025 |
Shift Lead (Upstream) |
Tuas South Avenue |
Singapour |
Operations |
Innovative Medicines |
Opérations techniques |
jan 31, 2025 |
E&I Engineer |
Tuas South Avenue |
Singapour |
Operations |
Innovative Medicines |
Opérations techniques |
jan 15, 2025 |
QC Specialist I - Biochemistry |
Tuas South Avenue |
Singapour |
Operations |
Innovative Medicines |
Qualité |
jan 15, 2025 |
QC Specialist II |
Tuas South Avenue |
Singapour |
Operations |
Innovative Medicines |
Qualité |
oct 10, 2024 |
QC Specialist I - Analytical |
Tuas South Avenue |
Singapour |
Operations |
Innovative Medicines |
Qualité |
Sep 03, 2024 |